Cargando…

Newly discovered atrial fibrillation: who(se) care(s)?

Detalles Bibliográficos
Autores principales:	Crijns, Harry J G M, Wijtvliet, E Petra J, Pluymaekers, Nikki A H A, Van Gelder, Isabelle C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203630/ https://www.ncbi.nlm.nih.gov/pubmed/32282897 http://dx.doi.org/10.1093/europace/euz359

Ejemplares similares

Rate control drugs differ in the prevention of progression of atrial fibrillation
por: Koldenhof, Tim, et al.
Publicado: (2021)

Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management
por: Pluymaekers, Nikki A.H.A., et al.
Publicado: (2019)

Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach
por: van der Velden, Rachel M.J., et al.
Publicado: (2022)

Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation
por: Van Der Velden, R, et al.
Publicado: (2023)

Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study
por: Nguyen, Bao Oanh, et al.
Publicado: (2020)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Frequency and Determinants of Spontaneous Conversion to Sinus Rhythm in Patients Presenting to the Emergency Department with Recent-onset Atrial Fibrillation: A Systematic Review
por: Pluymaekers, Nikki AHA, et al.
Publicado: (2020)

On‐demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation
por: Hermans, Astrid N. L., et al.
Publicado: (2020)

Hypnotic communication during atrial fibrillation ablation: Another clinical application of hypnotherapy?
por: den Uijl, Dennis W., et al.
Publicado: (2019)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

On-demand app-based rate and rhythm monitoring to manage atrial fibrillation through teleconsultations during COVID-19
por: Pluymaekers, Nikki A.H.A., et al.
Publicado: (2020)

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation
por: Van Noord, Trudeke, et al.
Publicado: (2005)

Paradigm shifts in pathophysiology and management of atrial fibrillation—a tale of the RACE trials in the Netherlands
por: Crijns, H. J. G. M., et al.
Publicado: (2020)

Extended ECG Improves Classification of Paroxysmal and Persistent Atrial Fibrillation Based on P- and f-Waves
por: Zink, Matthias Daniel, et al.
Publicado: (2022)

Atrial inflammation and atrial function after cardiac surgery: can we study it properly?
por: Dudink, Elton, et al.
Publicado: (2015)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care
por: Heijman, Jordi, et al.
Publicado: (2021)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017)

Mobile health solutions for atrial fibrillation detection and management: a systematic review
por: Hermans, Astrid N. L., et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation
por: Hermans, Astrid N.L., et al.
Publicado: (2021)

Short‐Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?
por: Ding, Wern Yew, et al.
Publicado: (2019)

Opportunities and challenges of large-scale screening for atrial fibrillation
por: Zink, Matthias Daniel, et al.
Publicado: (2018)

The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences
por: Gawałko, Monika, et al.
Publicado: (2021)

Incidence and outcome of atrial fibrillation: diversity throughout Europe
por: Rienstra, Michiel, et al.
Publicado: (2021)

New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?—Authors’ reply
por: Kawczynski, Michal J, et al.
Publicado: (2021)

Atrial Fibrillation
por: Gassanov, Natig, et al.
Publicado: (2013)

Atrial Fibrillation
por: Erol, Çetin
Publicado: (2022)

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
por: Rillig, Andreas, et al.
Publicado: (2021)

Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?
por: Smit, M. D., et al.
Publicado: (2011)

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
por: Aliot, Etienne, et al.
Publicado: (2011)

An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation
por: Cook, David A., et al.
Publicado: (2015)

Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2019)

Nonpharmacological Therapies for Atrial Fibrillation
por: Caldwell, Jane C., et al.
Publicado: (2011)

Atrial fibrillation in the elderly
por: Martínez-Sellés, Manuel, et al.
Publicado: (2017)

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Microglia: Newly discovered complexity could lead to targeted therapy for neonatal white matter injury and dysmaturation
por: Volpe, J.J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b153l954un1e3545e1vai8n5hk